'Developing a new drug is stumbling in the dark without a map. We are building the GPS'

22 mai 2022 | Sagi Cohen
When Immunai, a machine learning firm creating a ‘GPS’ for drug development, was just getting started a leading professor was skeptical about it – now he's their close consultant
 Site référencé:  Haaretz

Haaretz 

Putin 'will be gone by 2023,' ex-MI6 head predicts
24/05/2022
Israel lifted protections for Congolese asylum seekers without consulting Foreign Ministry
24/05/2022
The new battle in the Israeli right's relentless war on Palestinians
24/05/2022
Turkey's top diplomat pledges support for Palestinian independence in West Bank visit
24/05/2022
'Belittling the abduction of Yemenite kids is like Holocaust denial'
24/05/2022
Israel says exposed Palestinian plot to assassinate Kahanist lawmaker Ben-Gvir
24/05/2022